09.25.26 -- The Promise Of MRD-Guided CAR-T Treatment

Late-stage therapy trials demand strict execution. Learn how local handling variations escalate into global risks and how early standardization safeguards therapeutic integrity and compliance.

Only one in five eligible cell and gene therapy patients receives treatment. Expanding access into community hospitals requires overcoming significant operational and readiness barriers.

Investigational products present a distinctly high-risk environment for labeling and barcoding. Explore best practices for barcoding solutions that allow for improved medication safety in clinical trials.

As ADC science advances, operational strategy becomes critical. Read how smarter protocol design, real-time monitoring and collaborative execution can accelerate next-generation ADC trials.

Discover how precision medicine and novel therapeutics reshape lung cancer clinical development. Gain insights to overcome modern trial execution and global enrollment challenges.

Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.

Kelsey Powell explores the urgent need for better clinical research access in tribal healthcare, while Michele Baptista shares how her cancer journey led to a research opportunity that changed her life.